Form 20-F Valneva SE For: Dec 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260317/ANZZDG2COC22BZ2Z2M2Q2ZZ2CPB9Z22IZO82
Filed on: March 17, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026
- Wendy's Marks First Year in Romanian Market with Major Infrastructure Investments and Job Creation
- MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
